• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

The great unraveling of globalization









http://www.washingtonpost.com/busin...5425c2-e82e-11e4-aae1-d642717d8afa_story.html

Any thinking person could have seen this coming. You move manufacturing to low wage countries (with American tax payer dollars) and seriously expect low wage people to afford your goods and services?

The quality here sank over the last 10 years. At that point you need to ship the jobs over there. If you get the exact same product at a cheaper cost why would any company stay. Look at this place and everything we screwed up. We had no checks and balances. We have made many changes over the past 5 years. We forced people to take packages (fired) because they had no idea what QA was. The reason it's coming back is because we are doing it right now. It's capitalism at its best.